$name

Back

SANTA MONICA, Calif., May 26, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE), today announced that Arie Belldegrun, M.D., FACS, Chairman, President and Chief Executive Officer, will present a company overview at the Jefferies 2015 Global Healthcare Conference on June 2, 2015 at 11:00am Eastern Time. The conference will be held in New York, NY.

A live audio webcast of the presentation can be accessed through the Calendar of Events section of the Company's website at ir.kitepharma.com. A replay of the webcast will be available on the Company's website for two weeks following the presentation.

About Kite Pharma

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA.

CONTACT: Kite PharmaCynthia M. Butitta

         Chief Financial Officer and Chief Operating Officer

         310-824-9999



         For Media: Justin Jackson

         For Investor Inquiries: Lisa Burns and Carol WertherBurns McClellan

         212-213-0006

         jjackson@burnsmc.comlburns@burnsmc.comcwerther@burnsmc.com

Kite Pharma, Inc.

News Provided by Acquire Media